Cite
MLA Citation
Xiaozhong Chen et al.. “804 A phase II study of the anti-programmed cell death-1 (PD-1) antibody penpulimab in patients with metastatic nasopharyngeal carcinoma (NPC) who had progressed after two or more lines of chemotherapy.” Journal for immunotherapy of cancer, vol. 8, n.d., p. A481. http://access.bl.uk/ark:/81055/vdc_100144726490.0x000007